Evoke Pharma, Inc. - Common Stock (EVOK)
10.69
+0.03 (0.28%)
NASDAQ · Last Trade: Nov 5th, 6:31 PM EST
BALA CYNWYD, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · November 5, 2025
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Evoke Pharma, Inc. (NASDAQ: EVOK) to QOL Medical, LLC for $11.00 per share in cash is fair to Evoke shareholders.
By Halper Sadeh LLC · Via Business Wire · November 4, 2025